Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia

Journal of Clinical Oncology

Volumn 28, Issue 5, 2010, Pages 788-792

  Lacey Jr , James V ^a   Sherman, Mark E ^a   Rush, Brenda B ^a   Ronnett, Brigitte M ^a   Ioffe, Olga B ^a   Duggan, Máire A ^a   Glass, Andrew G ^a   Richesson, Douglas A ^a   Chatterjee, Nilanjan ^a   Langholz, Bryan ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE SEVERITY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; AGED; BIOPSY; CARCINOMA; DISEASE COURSE; ENDOMETRIUM TUMOR; HEALTH MAINTENANCE ORGANIZATION; HOSPITALIZATION; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PRECANCER; REGISTER; RISK ASSESSMENT; RISK FACTOR; TIME; UNITED STATES;

AGED; BIOPSY; CARCINOMA; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; KAPLAN-MEIERS ESTIMATE; MIDDLE AGED; OREGON; PRECANCEROUS CONDITIONS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 77649205666     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.24.1315     Document Type: Article

References (24)

1. Marsden DE, Hacker NF: Optimal management of endometrial hyperplasia. Best Pract Res Clin Obstet Gynaecol 15:393-405, 2001
2. McCluggage WG: My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol 59:801-812, 2006
3. Clark TJ, Neelakantan D, Gupta JK: The management of endometrial hyperplasia: An evaluation of current practice. Eur J Obstet Gynecol Reprod Biol 125:259-264, 2006
4. Silverberg SG, Mutter GL, Kurman RJ, et al: Tumors of the uterine corpus: Epithelial tumors and related lesions, in Tavassoli FA, Stratton MR (eds): WHO Classification of Tumors: Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Lyon, France, IARC Press, 2003, pp 221-232
5. Silverberg SG: Problems in the differential diagnosis of endometrial hyperplasia and carcinoma. Mod Pathol 13:309-327, 2000 (Pubitemid 30207515)
6. American College of Obstetricians and Gynecologists: ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 106:413-425, 2005
7. Trimble CL, Kauderer J, Zaino R, et al: Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: A Gynecologic Oncology Group study. Cancer 106:812-819, 2006 (Pubitemid 43238448)
8. Shutter J, Wright TC Jr: Prevalence of underlying adenocarcinoma in women with atypical endometrial hyperplasia. Int J Gynecol Pathol 24:313-318, 2005 (Pubitemid 41368281)
9. Valenzuela P, Sanz JM, Keller J: Atypical endometrial hyperplasia: Grounds for possible misdiagnosis of endometrial adenocarcinoma. Gynecol Obstet Invest 56:163-167, 2003 (Pubitemid 37346765)
10. Zaino RJ: Endometrial hyperplasia: Is it time for a quantum leap to a new classification? Int J Gynecol Pathol 19:314-321, 2000
11. Ferenczy A, Gelfand M: The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol 160:126-131, 1989 (Pubitemid 19055273)
12. Lindahl B, Willen R: Spontaneous endometrial hyperplasia: A prospective, 5 year follow-up of 246 patients after abrasion only, including 380 patients followed-up for 2 years. Anticancer Res 14:2141-2146, 1994
13. Tabata T, Yamawaki T, Yabana T, et al: Natural history of endometrial hyperplasia: Study of 77 patients. Arch Gynecol Obstet 265:85-88, 2001 (Pubitemid 32494271)
14. Terakawa N, Kigawa J, Taketani Y, et al: The behavior of endometrial hyperplasia: A prospective study - Endometrial Hyperplasia Study Group. J Obstet Gynaecol Res 23:223-230, 1997
15. Horn LC, Schnurrbusch U, Bilek K, et al: Risk of progression in complex and atypical endometrial hyperplasia: Clinicopathologic analysis in cases with and without progestogen treatment. Int J Gynecol Cancer 14:348-353, 2004 (Pubitemid 38533908)
16. Lacey JV Jr, Ioffe OB, Ronnett BM, et al: Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: The 34-year experience in a large health plan. Br J Cancer 98:45-53, 2008
17. Pepe MS, Janes H, Longton G, et al: Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J Epidemiol 159:882-890, 2004 (Pubitemid 38657490)
18. Wagner EH, Greene SM, Hart G, et al: Building a research consortium of large health systems: The Cancer Research Network. J Natl Cancer Inst Monogr 2005:3-11, 2005
19. Mazur MT: Endometrial hyperplasia/adenocarcinoma: A conventional approach. Ann Diagn Pathol 9:174-181, 2005
20. Langholz B, Clayton D: Sampling strategies in nested case-control studies. Environ Health Perspect. 102:47-51, 1994 (suppl 8) (Pubitemid 24373309)
21. Langholz B, Borgan O: Estimation of absolute risk from nested case-control data. Biometrics 53:767-774, 1997 (Pubitemid 27262238)
22. Ries LAG, Melbert D, Krapcho M, et al (eds): Surveillance, Epidemiology, and End Results (SEER) Cancer Statistics Review, 1975-2005. Bethesda, MD, National Cancer Institute, 2008.
23. Kurman RJ, Kaminski PF, Norris HJ: The behavior of endometrial hyperplasia: A long-term study of untreated hyperplasia in 170 patients. Cancer 56:403-412, 1985
24. Sherman ME, Ronnett BM, Ioffe OB, et al: Reproducibility of biopsy diagnoses of endometrial hyperplasia: Evidence supporting a simplified classification. Int J Gynecol Pathol 27:318-325, 2008